Evaluating the Renal Safety and Benefits of Sodium-Glucose Cotransporter-2 Inhibitors among Type 2 Diabetes Patients with Moderate-To-Severe Chronic Kidney Disease by Real-World Data

2023-08-012024-05-18https://scholars.lib.ntu.edu.tw/handle/123456789/709289Evaluating the Renal Safety and Benefits of Sodium-Glucose Cotransporter-2 Inhibitors among Type 2 Diabetes Patients with Moderate-To-Severe Chronic Kidney Disease by Real-World Data